fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Suven Life Sciences Ltd

Suven Life Sciences Ltd

Updated on May 26, 2020

Stock/Share Code - SUVEN

Suven Life Sciences is engaged in providing building blocks (bulk actives, drug intermediates and speciality chemicals) for global life science companies.

Below is the details of SUVEN Suven Life Sciences Ltd

Market Cap₹434.03 Cr.
Current Price ₹34.4 as on 1 Jun 20
52 Week High / Low Price₹67.5 / ₹15.04
Face Value₹1
Stock P/E3.97
Book Value₹88.22
Dividend Yield4.40 %
ROCE21.18 %
ROE14.61 %
Sales Growth (3yrs)9.93 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Stock is trading at 0.39 times its book value Stock is providing a good dividend yield of 4.40%.
Cons: The company has delivered a poor growth of 5.39% over past five years. Debtor days have increased from 49.78 to 82.62 days.

Suven Life Sciences Ltd Price Chart

Suven Life Sciences Ltd Price Chart

Suven Life Sciences Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Divi's Lab. ₹107.95 49.56 ₹63,449.65 Cr. 0.67 ₹359.09 Cr. -7.78 2.67 1396.26 28.51
2. Lupin ₹849.7 ₹39,407.16 Cr. 0.57 ₹389.63 Cr. 12.32 -1.05 3845.74 9.97
3. Jubilant Life ₹464.25 7.64 ₹7,043.45 Cr. 1.13 ₹260.49 Cr. 248.25 0.24 2391.41 16.37
4. Granules India ₹171.3 13.30 ₹4,353.99 Cr. 0.58 ₹64.03 Cr. 39.82 11.42 703.96 14.75
5. Shilpa Medicare ₹393.65 21.97 ₹3,203.19 Cr. 0.28 ₹55.06 Cr. 248.70 36.57 236.85 8.74
6. Aarti Drugs ₹955.6 17.47 ₹2,265.34 Cr. 0.21 ₹56.56 Cr. 118.69 -6.00 406.57 17.00
7. Sequent Scien. ₹85.55 30.12 ₹2,106.19 Cr. 0.24 ₹16.86 Cr. -1.52 6.72 300.83 9.21
8. Suven Life Scie. 3.97 ₹434.03 Cr. 4.40 -₹4.5 Cr. 45.91 31.28 2.77 21.18

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Suven Life Sciences Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019
Sales -18014110716421419290225319913
YOY Sales Growth %6.36%5.85%-7.52%41.64%18.63%35.91%-16.23%-98.71%18.52%3.82%-98.45%31.28%
Expenses -132966211212213365161481091412
Material Cost %36%25%10%30%28%34%6%0%30%21%0%0%
Employee Cost %8%11%12%9%7%9%16%299%7%9%302%87%
Operating Profit48454551915824-1410590-13-9
OPM %27%32%42%31%43%30%27%-648%42%45%-900%-338%
Other Income565398774326
Interest211111102100
Depreciation755556615611
Profit before tax44444448946025-810286-12-4
Tax %10%33%28%28%33%35%28%-5%33%34%4%-1%
Net Profit40303235633918-86857-11-4
EPS in Rs3.172.322.492.724.913.051.41-0.655.344.49-0.88-0.35
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales -117140129150204258510521499543625663456
Sales Growth %4.99%19.30%-7.75%16.49%35.78%26.26%97.99%2.07%-4.15%8.80%15.09%6.10%
Expenses -105122116137181205291361369378392440283
Material Cost %37.99%34.88%30.11%36.55%37.14%32.07%26.75%34.70%33.33%27.95%24.79%26.16%
Manufacturing Cost %14.75%12.65%12.71%14.21%13.66%15.24%10.64%12.47%15.01%14.94%14.04%15.21%
Employee Cost %11.04%11.60%12.20%12.48%11.19%9.85%6.16%7.01%8.20%9.32%9.40%9.57%
Other Cost %25.42%28.41%34.55%27.73%26.67%22.20%13.52%15.21%17.45%17.35%14.52%15.36%
Operating Profit131713142353219159130165233224173
OPM %11%12%10%9%11%21%43%31%26%30%37%34%38%
Other Income3-10121391921232415
Interest5756101411566543
Depreciation4555689121821212213
Profit before tax6543933203152126159230222172
Tax %-32%-40%-89%-219%-57%6%29%28%20%23%31%32%
Net Profit877101431144109100123158150109
EPS in Rs0.680.570.560.851.182.6412.348.547.869.7012.4511.798.60
Dividend Payout %35%41%41%28%24%11%20%7%25%10%12%13%

Compounded Sales Growth

  • 10 Years:: 16.84%
  • 5 Years:: 5.39%
  • 3 Years:: 9.93%
  • TTM:: -8.16%

Compounded Profit Growth

  • 10 Years:: 26.98%
  • 5 Years:: -1.18%
  • 3 Years:: 15.85%
  • TTM:: -1.45%

Return on Equity

  • 10 Years:: 33.34%
  • 5 Years:: 14.16%
  • 3 Years:: 37.74%
  • 1 Year:: 81.48%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital -12121212121212131313131313
Equity Capital11.5711.5911.5911.6711.6711.6811.6812.7312.7312.7312.7312.73
Reserves1011031061151161432535476117198549811,110
Borrowings5543506698117911098371343887
Other Liabilities -3829373160561321056874114143186
Trade Payables19202619253641443638576149
Advance from Customers013081005884
Other liability items1878122619916127284979137
Total Liabilities2041862052242853284877737748761,0141,1751,396
Fixed Assets -110112110106132162179172305306308293284
Gross Block141151156160199238267291325349376387
Accumulated Depreciation3139465466778811920436894
CWIP44332441310771025111138
Investments861220500023366381366502
Other Assets -83648094124162295494438195301404472
Inventories24273033465479828393139157152
Trade receivables3521333125246540544662150163
Cash Equivalents3123322682802415211358
Loans n Advances4139394868797178939495855
Other asset items-22-25-24-21-19-171214-33-42-16-194
Total Assets2041862052242853284877737748761,0141,1751,396

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity -43413534311211439014710576
Profit from operations182516173055219172137172241230
Receivables-2011-8-40-15-4925-138-16-89
Inventory-2-3-3-3-12-7-25-3-2-9-47-18
Payables829-5174163-82194
Loans Advances0000000-50000
Direct taxes-1-1-0-0-2-6-41-38-27-35-44-47
Other operating items0000000-1239-48-5
Cash from Investing Activity --16-15-10-12-32-15-36-110-62-353-38-62
Fixed assets purchased-19-12-5-4-27-20-38-118-58-31-42-98
Fixed assets sold000000000000
Investments purchased0-4-5-9-5000-23-343-37-34
Investments sold3000040016204070
Interest received000000122110
Dividends received000011160000
Other investing items0000-0-0-0-000-0-0
Cash from Financing Activity -6-21-28-23-38179-68-30-52-23
Proceeds from shares0.830.340.001.690.000.200.00200.000.000.000.000.00
Proceeds from borrowings13.120.006.9515.6911.390.000.0018.26-4.076.320.094.72
Repayment of borrowings0.00-11.500.000.000.000.000.00-0.32-17.76-15.71-24.55-0.45
Interest paid fin-5.06-6.25-5.44-6.10-9.83-12.84-7.63-4.64-5.87-5.67-4.61-3.76
Dividends paid-3.37-3.38-3.39-3.40-3.39-4.07-4.10-34.17-39.83-12.73-22.98-23.02
Other financing items0.000.000.000.000.0019.26-26.500.00-0.52-2.590.000.00
Net Cash Flow-7-211-01947212-40-23615-8

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %7%11%5%5%9%19%68%31%17%19%25%21%
Debtor Days1105692764534472839313683
Inventory Turnover4.965.424.474.715.115.147.716.496.046.175.394.47

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Suven Life Sciences Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.